Loading…
Leupaxin Is a Novel LIM Domain Protein That Forms a Complex with PYK2
We have identified a novel cytoplasmic protein, leupaxin, that is preferentially expressed in hematopoietic cells and is most homologous to the focal adhesion protein, paxillin. Leupaxin possesses two types of protein interaction domains. There are four carboxyl-terminal LIM domains in leupaxin that...
Saved in:
Published in: | The Journal of biological chemistry 1998-05, Vol.273 (19), p.11709-11713 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | We have identified a novel cytoplasmic protein, leupaxin, that is preferentially expressed in hematopoietic cells and is most
homologous to the focal adhesion protein, paxillin. Leupaxin possesses two types of protein interaction domains. There are
four carboxyl-terminal LIM domains in leupaxin that share 70% amino acid identity and 80% similarity with those in paxillin.
Paxillin LIM domains mediate localization to focal contacts. In the amino-terminal region of leupaxin there are three short
stretches of approximately 13 amino acids that share 70â90% similarity with paxillin LD motifs. Paxillin LD motifs have been
implicated in focal adhesion kinase (FAK) and vinculin binding resulting in the localization of FAK to focal adhesions. Leupaxin
is expressed in cell types, such as macrophage, that lack FAK. We demonstrate here that leupaxin associates with a second
FAK family member, PYK2. As leupaxin and PYK2 are both preferentially expressed in leukocytes they may therefore form a cell
type-specific signaling complex. We also demonstrate that leupaxin is a substrate for a tyrosine kinase in lymphoid cells
and thus may function in and be regulated by tyrosine kinase activity. Leupaxin is thus a phosphotyrosine protein with LD
and LIM binding motifs most homologous to paxillin that may assemble and regulate PYK2 signaling complexes in leukocytes. |
---|---|
ISSN: | 0021-9258 1083-351X |
DOI: | 10.1074/jbc.273.19.11709 |